---
title: Share capital increase registered
description: Share capital increase registered
---

Moss, 9 December 2021

Reference is made to the stock exchange notice from Gentian Diagnostics ASA (the  
"Company") on 29 November 2021 regarding a share issue in connection with an  
employee share purchase program (ESPP), by issuance of 10,641 new shares in the  
Company at a subscription price of NOK 54.49 per new share. The share capital  
increase pertaining to the ESPP is now registered with the Norwegian Register of  
Business Enterprises. The Company's new registered share capital is NOK  
1,542,235.0 divided on 15,422,350 shares, each with a nominal value of NOK 0.10.

This information is subject to the disclosure requirements pursuant to section  
5-12 of the Norwegian Securities Trading Act.

For further information, please contact:

Njaal Kind  
CFO, Gentian Diagnostics  
E-mail: njaal.kind@gentian.no  
Cell Phone: +47 919 06 525

**More information:**  
[Access the news on Oslo Bors NewsWeb site](https://newsweb.oslobors.no/message/548948)

### You may also read

[Jul 02, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/share-capital-increase-registered-2#)

##### [Gentian Diagnostics: Invitation to presentation of second quarter results](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

Gentian Diagnostics ASA will present its second quarter 2026 results on 9 July 2026 at 09.00 CEST. The..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/gentian-diagnostics-invitation-to-presentation-of-second-quarter-results-1)

[Jun 24, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/share-capital-increase-registered-2#)

##### [ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

Amsterdam / Moss, 24 June 2026 ESSANGE REAGENTS AND GENTIAN DIAGNOSTICS ANNOUNCE COLLABORATION AGREEMENT..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/essange-reagents-and-gentian-diagnostics-announce-collaboration-agreement)

[May 29, 2026 - Ole Sørlie](https://www.gentian.com/investor-relations-stock-information/investors-news/share-capital-increase-registered-2#)

##### [Mandatory notification of trade](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)

Moss, 29 May 2026 Gentian Diagnostics ASA ("Gentian") has today been notified that the following transaction..

[Read more](https://www.gentian.com/investor-relations-stock-information/investors-news/mandatory-notification-of-trade-1780055230560)